Conduent Toekomstige groei

Future criteriumcontroles 0/6

De omzet en winst van Conduent zullen naar verwachting dalen met respectievelijk 6.4% en 73% per jaar, terwijl de winst per aandeel naar verwachting zal dalen met 74.1% per jaar.

Belangrijke informatie

-73.0%

Groei van de winst

-74.1%

Groei van de winst per aandeel

Professional Services winstgroei	15.5%
Inkomstengroei	-6.4%
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Low
Laatst bijgewerkt	31 Oct 2024

Recente toekomstige groei-updates

Recent updates

Insufficient Growth At Conduent Incorporated (NASDAQ:CNDT) Hampers Share Price

Oct 26

Is Conduent (NASDAQ:CNDT) A Risky Investment?

Sep 15

Conduent Incorporated (NASDAQ:CNDT) Surges 35% Yet Its Low P/S Is No Reason For Excitement

Jul 24

Winst- en omzetgroeiprognoses

NasdaqGS:CNDT - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2025	3,279	-55	84	174	2
12/31/2024	3,385	323	62	152	2
6/30/2024	3,634	22	-64	33	N/A
3/31/2024	3,721	-201	-28	64	N/A
12/31/2023	3,722	-306	-4	89	N/A
9/30/2023	3,755	-645	-89	18	N/A
6/30/2023	3,800	-341	15	127	N/A
3/31/2023	3,813	-334	-4	121	N/A
12/31/2022	3,858	-192	-9	144	N/A
9/30/2022	3,920	101	22	178	N/A
6/30/2022	3,981	97	-24	135	N/A
3/31/2022	4,079	109	89	256	N/A
12/31/2021	4,140	-38	96	243	N/A
9/30/2021	4,147	-9	185	330	N/A
6/30/2021	4,150	-27	232	382	N/A
3/31/2021	4,140	-90	206	351	N/A
12/31/2020	4,163	-128	22	161	N/A
9/30/2020	4,207	-698	185	337	N/A
6/30/2020	4,264	-707	86	248	N/A
3/31/2020	4,360	-1,685	-180	-11	N/A
12/31/2019	4,467	-1,944	-83	132	N/A
9/30/2019	4,650	-1,503	-195	37	N/A
6/30/2019	4,856	-1,724	-258	-11	N/A
3/31/2019	5,131	-684	17	272	N/A
12/31/2018	5,393	-426	59	283	N/A
9/30/2018	5,604	-78	67	266	N/A
6/30/2018	5,780	142	230	400	N/A
3/31/2018	5,889	127	N/A	369	N/A
12/31/2017	6,022	167	N/A	300	N/A
9/30/2017	6,043	-989	N/A	210	N/A
6/30/2017	6,159	-969	N/A	246	N/A
3/31/2017	6,276	-972	N/A	118	N/A
12/31/2016	6,408	-983	N/A	95	N/A
9/30/2016	6,624	-23	N/A	450	N/A
6/30/2016	6,599	-260	N/A	438	N/A
3/31/2016	6,669	-353	N/A	517	N/A
12/31/2015	6,662	-336	N/A	493	N/A
12/31/2014	6,938	34	N/A	665	N/A
12/31/2013	6,879	135	N/A	379	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De winst van CNDT zal naar verwachting de komende 3 jaar dalen ( -73% per jaar).

Winst versus markt: De winst van CNDT zal naar verwachting de komende 3 jaar dalen ( -73% per jaar).

Hoge groeiwinsten: De winst van CNDT zal naar verwachting de komende 3 jaar dalen.

Omzet versus markt: De omzet van CNDT zal naar verwachting de komende 3 jaar dalen ( -6.4% per jaar).

Hoge groei-inkomsten: De omzet van CNDT zal naar verwachting de komende 3 jaar dalen ( -6.4% per jaar).

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van CNDT naar verwachting over 3 jaar hoog zal zijn

Conduent Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Conduent Incorporated Provides Earnings Guidance for the Full Year 2024

Consensus EPS estimates upgraded to US$0.20 loss

Price target decreased to US$3.75

Consensus forecasts updated

Price target decreased to US$6.50

Forecast breakeven date pushed back to 2023

Recent updates

Insufficient Growth At Conduent Incorporated (NASDAQ:CNDT) Hampers Share Price

Conduent Incorporated to Report Q3, 2024 Results on Nov 06, 2024

Is Conduent (NASDAQ:CNDT) A Risky Investment?

Conduent Incorporated Announces Executive Changes

Investor sentiment improves as stock rises 16%

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Conduent Incorporated (NASDAQ:CNDT) Surges 35% Yet Its Low P/S Is No Reason For Excitement

Conduent Incorporated to Report Q2, 2024 Results on Aug 07, 2024

Conduent Selling Subsidiaries To Enable Profitable Growth

Independent Director notifies of intention to sell stock

Is Conduent (NASDAQ:CNDT) A Risky Investment?

MedRisk, LLC agreed to acquire Conduent Casualty Claims Solutions LLC from Conduent Incorporated (NasdaqGS:CNDT) for approximately $240 million.

MedRisk, LLC agreed to acquire Conduent Casualty Claims Solutions LLC from Conduent Incorporated (NasdaqGS:CNDT) for approximately $240 million.

Conduent Incorporated Provides Earnings Guidance for the Full Year 2024

First quarter 2024 earnings released: EPS: US$0.46 (vs US$0.037 loss in 1Q 2023)

Conduent Incorporated to Report Q1, 2024 Results on May 01, 2024

Conduent Incorporated, Annual General Meeting, May 17, 2024

New minor risk - Profitability

Returns On Capital Are Showing Encouraging Signs At Conduent (NASDAQ:CNDT)

Full year 2023 earnings: EPS exceeds analyst expectations

Conduent Incorporated to Report Q4, 2023 Results on Feb 14, 2024

Is Conduent (NASDAQ:CNDT) Using Too Much Debt?

Conduent Transportation Develops New Software Platform to Transform Ticket Vending Machines First Used by Trenord in Italy

Conduent Incorporated Announces Goodwill Impairment for Three Months Ended September 30, 2023

Third quarter 2023 earnings released

New major risk - Revenue and earnings growth

Is Conduent (NASDAQ:CNDT) A Risky Investment?

Conduent Incorporated Announces its Latest Finance, Accounting and Procurement Software Solution, Fastcap Finance Analytics

Conduent Incorporated to Report Q3, 2023 Results on Nov 01, 2023

Conduent (NASDAQ:CNDT) Is Experiencing Growth In Returns On Capital

Consensus EPS estimates upgraded to US$0.20 loss

Insufficient new directors

Second quarter 2023 earnings released: US$0.04 loss per share (vs US$0.014 loss in 2Q 2022)

Conduent Incorporated to Offer U.S. Federal Reserve’s FedNow? Service for Instant Payments

Conduent Incorporated Presents Financing Solutions to Support Lenders at NAF Association Non-Prime Auto Financing Conference

Conduent Incorporated, Annual General Meeting, May 24, 2023

Conduent Incorporated Announces A New Provider Data Management Solution

Conduent (NASDAQ:CNDT) Is Looking To Continue Growing Its Returns On Capital

Conduent Incorporated (NasdaqGS:CNDT) announces an Equity Buyback for $75 million worth of its shares.

President recently bought US$100k worth of stock

First quarter 2023 earnings released: US$0.04 loss per share (vs US$0.62 profit in 1Q 2022)

These 4 Measures Indicate That Conduent (NASDAQ:CNDT) Is Using Debt Extensively

Full year 2022 earnings released: US$0.89 loss per share (vs US$0.18 loss in FY 2021)

Conduent Incorporated Reports Impairment Charges for the Fourth Quarter Ended December 31, 2022

Conduent (NASDAQ:CNDT) Is Experiencing Growth In Returns On Capital

Conduent Incorporated to Report Q4, 2022 Results on Feb 14, 2023

Conduent Launches IntelliHealth Module for Healthcare Provider Engagement

We Think Conduent (NASDAQ:CNDT) Can Stay On Top Of Its Debt

Conduent Incorporated Releases Enhanced Viewpoint eDiscovery 7.5 Platform

Price target decreased to US$3.75

Conduent Introduces Benepath® Suite of Solutions to Assist States with Eligibility and Enrollment for Medicaid, Snap and Other Benefit Programs

Third quarter 2022 earnings released: EPS: US$0.06 (vs US$0.042 in 3Q 2021)

Conduent Incorporated to Report Q3, 2022 Results on Nov 01, 2022

Conduent (NASDAQ:CNDT) Is Looking To Continue Growing Its Returns On Capital

Conduent Incorporated Deeply Engages Disease Surveillance for the Past 20 Years with the Development of the Maven(R) Disease Surveillance & Outbreak Management Platform

We Think Conduent (NASDAQ:CNDT) Is Taking Some Risk With Its Debt

President recently bought US$202k worth of stock

Second quarter 2022 earnings: Revenues in line with analyst expectations

Conduent Q2 2022 Earnings Preview

Conduent (NASDAQ:CNDT) Is Doing The Right Things To Multiply Its Share Price

Conduent Incorporated to Report Q2, 2022 Results on Aug 02, 2022

Investor sentiment deteriorated over the past week

Conduent (NASDAQ:CNDT) Strong Profits May Be Masking Some Underlying Issues

Consensus forecasts updated

Conduent Incorporated Showcases its Legal Spend and Contract Analytics Tools at CLOC Global Institute

President recently bought US$100k worth of stock

First quarter 2022 earnings: EPS exceeds analyst expectations

Conduent Incorporated Announces Two New Enhancements to its Highly Configurable Strataware Medical Bill Review Platform

Price target decreased to US$6.50